A Mild Inhibition of Cathepsin K Paradoxically Stimulates the Resorptive Activity of Osteoclasts in Culture

[1]  C. Overall,et al.  Aging-associated modifications of collagen affect its degradation by matrix metalloproteinases. , 2017, Matrix biology : journal of the International Society for Matrix Biology.

[2]  J. Delaissé,et al.  An Ectosteric Inhibitor of Cathepsin K Inhibits Bone Resorption in Ovariectomized Mice , 2017, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[3]  S. Khosla,et al.  Cathepsin K Inhibitors for Osteoporosis: Biology, Potential Clinical Utility, and Lessons Learned , 2017, Endocrine reviews.

[4]  J. Delaissé,et al.  Osteoclast Fusion: Time‐Lapse Reveals Involvement of CD47 and Syncytin‐1 at Different Stages of Nuclearity , 2016, Journal of cellular physiology.

[5]  N. Chattopadhyay,et al.  Pharmacological inhibition of cathepsin K: A promising novel approach for postmenopausal osteoporosis therapy. , 2016, Biochemical pharmacology.

[6]  D. Brömme,et al.  Cathepsin K osteoporosis trials, pycnodysostosis and mouse deficiency models: Commonalities and differences , 2016, Expert opinion on drug discovery.

[7]  J. Delaissé,et al.  A novel approach to inhibit bone resorption: exosite inhibitors against cathepsin K , 2016, British journal of pharmacology.

[8]  M. Ding,et al.  Pit- and trench-forming osteoclasts: a distinction that matters , 2015, Bone Research.

[9]  G. Brayer,et al.  Structural basis of collagen fiber degradation by cathepsin K , 2014, Proceedings of the National Academy of Sciences.

[10]  L. Duong,et al.  Inhibition of bone resorption by the cathepsin K inhibitor odanacatib is fully reversible. , 2014, Bone.

[11]  J. Delaissé,et al.  Steering the osteoclast through the demineralization-collagenolysis balance. , 2013, Bone.

[12]  Hongbin Li,et al.  Effects of Cysteine Proteases on the Structural and Mechanical Properties of Collagen Fibers* , 2013, The Journal of Biological Chemistry.

[13]  L. Duong.  Therapeutic inhibition of cathepsin K-reducing bone resorption while maintaining bone formation. , 2012, BoneKEy reports.

[14]  L. Duong,et al.  The effects of the cathepsin K inhibitor odanacatib on osteoclastic bone resorption and vesicular trafficking. , 2011, Bone.

[15]  J. Delaissé,et al.  Glucocorticoids maintain human osteoclasts in the active mode of their resorption cycle , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[16]  J. Eisman,et al.  Odanacatib, a cathepsin‐K inhibitor for osteoporosis: A two‐year study in postmenopausal women with low bone density , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[17]  M. Percival,et al.  Pharmacological inhibitors to identify roles of cathepsin K in cell-based studies: a comparison of available tools , 2009, Biological chemistry.

[18]  M. Kumegawa,et al.  Quantification of the expression levels of lysosomal cysteine proteinases in purified human osteoclastic cells by competitive RT-PCR , 2007, Calcified Tissue International.

[19]  C. Peters,et al.  Osteoclastic Bone Degradation and the Role of Different Cysteine Proteinases and Matrix Metalloproteinases: Differences Between Calvaria and Long Bone , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[20]  J. Falgueyret,et al.  Identification of a potent and selective non-basic cathepsin K inhibitor. , 2006, Bioorganic & medicinal chemistry letters.

[21]  E. Vuorio,et al.  Impaired bone resorption in cathepsin K-deficient mice is partially compensated for by enhanced osteoclastogenesis and increased expression of other proteases via an increased RANKL/OPG ratio. , 2005, Bone.

[22]  V. Bhalla,et al.  inhibition in , 2005 .

[23]  J. Delaissé,et al.  A scrutiny of matrix metalloproteinases in osteoclasts: evidence for heterogeneity and for the presence of MMPs synthesized by other cells. , 2004, Bone.

[24]  R. Maciewicz,et al.  Cathepsin L‐deficient mice exhibit abnormal skin and bone development and show increased resistance to osteoporosis following ovariectomy , 2004, International journal of experimental pathology.

[25]  D. Brömme,et al.  Production and activation of recombinant papain-like cysteine proteases. , 2004, Methods.

[26]  J. Delaissé,et al.  Matrix metalloproteinases (MMP) and cathepsin K contribute differently to osteoclastic activities , 2003, Microscopy research and technique.

[27]  M. Karsdal,et al.  The Type I Collagen Fragments ICTP and CTX Reveal Distinct Enzymatic Pathways of Bone Collagen Degradation , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[28]  P. Saftig,et al.  The Bone Lining Cell: Its Role in Cleaning Howship's Lacunae and Initiating Bone Formation , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[29]  M. Kumegawa,et al.  Erratum to: Quantification of the Expression Levels of Lysosomal Cysteine Proteinases in Purified Human Osteoclastic Cells by Competitive RT-PCR , 2001, Calcified Tissue International.

[30]  Y. Ru,et al.  Potent and Selective Cathepsin L Inhibitors Do Not Inhibit Human Osteoclast Resorption in Vitro * , 2001, The Journal of Biological Chemistry.

[31]  Thiennu H. Vu,et al.  Matrix Metalloproteinase 9 and Vascular Endothelial Growth Factor Are Essential for Osteoclast Recruitment into Developing Long Bones , 2000, The Journal of cell biology.

[32]  J. Palmer,et al.  Localization of Rat Cathepsin K in Osteoclasts and Resorption Pits: Inhibition of Bone Resorption and Cathepsin K-Activity by Peptidyl Vinyl Sulfones , 1999, Biological chemistry.

[33]  P. Delmas,et al.  The Collagenolytic Activity of Cathepsin K Is Unique among Mammalian Proteinases* , 1998, The Journal of Biological Chemistry.

[34]  Sheila J. Jones,et al.  Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[35]  L. Creemers,et al.  Participation of intracellular cysteine proteinases, in particular cathepsin B, in degradation of collagen in periosteal tissue explants. , 1998, Matrix biology : journal of the International Society for Matrix Biology.

[36]  Y. Okada,et al.  Membrane Type 1 Matrix Metalloproteinase Digests Interstitial Collagens and Other Extracellular Matrix Macromolecules* , 1997, The Journal of Biological Chemistry.

[37]  Jian Zhang,et al.  Cathepsin K: isolation and characterization of the murine cDNA and genomic sequence, the homologue of the human pycnodysostosis gene. , 1996, Biochemical and molecular medicine.

[38]  C. Debouck,et al.  Cathepsin K, but Not Cathepsins B, L, or S, Is Abundantly Expressed in Human Osteoclasts (*) , 1996, The Journal of Biological Chemistry.

[39]  J. Mort,et al.  The septoclast, a cathepsin B-rich cell involved in the resorption of growth plate cartilage. , 1995, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[40]  Sheila J. Jones,et al.  Inhibition of bone resrption by selctive inactivators of cysteine proteinases , 1994, Journal of cellular biochemistry.

[41]  P. Tulkens,et al.  Increased activities of cathepsin B and other lysosomal hydrolases in fibroblasts and bone tissue cultured in the presence of cysteine proteinases inhibitors. , 1994, Life sciences.

[42]  Bonnie F. Sloane,et al.  Human tumour cathepsin B. Comparison with normal liver cathepsin B. , 1992, The Biochemical journal.

[43]  J. Delaissé,et al.  Degradation of collagen in the bone‐resorbing compartment underlying the osteoclast involves both cysteine‐proteinases and matrix metalloproteinases , 1992, Journal of cellular physiology.

[44]  R. Maciewicz,et al.  Susceptibility of the cartilage collagens types II, IX and XI to degradation by the cysteine proteinases, cathepsins B and L , 1990, FEBS letters.

[45]  V. Sukhatme,et al.  Synthesis and processing of cathepsin L, an elastase, by human alveolar macrophages. , 1989, The Biochemical journal.

[46]  T. Tsukahara,et al.  Autodegradation of lysosomal cysteine proteinases. , 1987, Biochemical and biophysical research communications.

[47]  Sheila J. Jones,et al.  The effects of inhibitors of cysteine-proteinases and collagenase on the resorptive activity of isolated osteoclasts. , 1987, Bone.

[48]  J. Sutherland,et al.  Paradoxical effect of leupeptin in vivo on cathepsin B activity. , 1983, Biochemical and biophysical research communications.

[49]  N. Ikegaki,et al.  Effects of leupeptin and pepstatin on protein turnover in adult rat hepatocytes in primary culture. , 1981, Archives of biochemistry and biophysics.